First clinical trial evaluates stem cell therapy for Huntington’s disease

Post author:admin
Post published:July 9, 2026
Post category:uncategorized

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington’s disease was presented today at the ISSCR 2026 Annual Meeting.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Calcium-induced release identified as key driver of dangerous muscle disorders

Exploring exercise’s physiological response to fight diabetes

New brain map reveals insights into multiple sclerosis development

Helpful Links

Subscribe To Us